Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

CareDx Q4 2023 Adj EPS $(0.17) Beats $(0.27) Estimate, Sales $65.57M Beat $63.66M Estimate

Author: Benzinga Newsdesk | February 28, 2024 05:14pm
CareDx (NASDAQ:CDNA) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.27) by 37.04 percent. The company reported quarterly sales of $65.57 million which beat the analyst consensus estimate of $63.66 million by 3.01 percent. This is a 20.41 percent decrease over sales of $82.38 million the same period last year.

Posted In: CDNA


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist